Nature, Published online: 11 November 2026; doi:10.1038/d41586-026-03640-9
A promising biotechnology company developed a new approach that might treat a rare disease — but its sole employee didn’t do all the work.AI & ML
Anthropic bought a one-person, AI-powered biotech: is this drug discovery’s future?
Nature News0 views
Source:https://www.nature.com/articles/d41586-026-03640-9
PreviousRattlesnakes have personalities too — to venomous effectNextEngineered bacteria are weaning farms away from synthetic fertilizers
Related posts
Give internal links an acceptance test before a template release
0dev.to

Codex 的三种新工作流:云端交接、语音调度与个人智能体
0dev.to

Google Says Gemini App Rolling Out on Apple CarPlay Starting Today
0MacRumors
Type 0.73: Earth on the Kardashev scale, and why AI is short of wire
0Hacker News New
Tools for exploring the souls of large language models
0Hacker News New
Should we fear Q-Day how to think calmly about invisible risks
0Hacker News New